News Releases

News Releases

June 12, 2018
MeiraGTx Announces Closing of Initial Public Offering

LONDON and NEW YORK , June 12, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the closing of its initial public offering of 5,000,000 ordinary shares at a public offering price of $15.00 per share.

June 7, 2018
MeiraGTx Announces Pricing of Initial Public Offering
LONDON and NEW YORK, June 07, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (the “Company”), a vertically integrated, clinical stage gene therapy company, today announced the pricing of its initial public offering of 5,000,000 ordinary shares at a public offering price of $15.00 per share, for
Displaying 11 - 17 of 17